Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Eoganacht

V.TLT

RE:An example of deceptive headlines for Adstiladrin

Yes - very deceptive. And this kind of thing is done a lot. If Theralase...

December 9, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:28 places in this most recent private placement

Cheers Rump We may not get 66% but 45% - 50% is still possible...

December 9, 2023

V.TLT

RE:RE:Optimal Management of Bacillus Calmette-Guérin–Refractory No

Those are our results but they're old. They're from Aug. 29 2022...

December 9, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:28 places in this most recent private placement

Back in 2016 Dr. Kamat and colleagues wrote that a clinically meaningful CRR...

December 8, 2023

V.TLT

RE:RE:28 places in this most recent private placement

Thanks riverrow - very interesting. It looks like Roger was the only insider...

December 6, 2023

V.TLT

Did the FDA Move the BTD Goal Posts?

Or did events just catch up with us....? It may be no coincidence that at...

December 4, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RDW on youtube posted today

I'm hoping that Drs. Kamat and Kulkarni will help to spread the word...

December 3, 2023

V.TLT

RE:RE:Six months from now...

I think the current situation is because of the unexplained delays in...

November 30, 2023

V.TLT

Six months from now...

...we will get the 30 May 2024 MD&A. Currently there are 4 patients at...

November 30, 2023

V.TLT

RE:RE:RE:RE:1St quarter BTD

I don't know if the FDA required them - but they did allow them. For all...

November 29, 2023

V.TLT

RE:RE:1St quarter BTD

9. Look at all those CRs at 360 270 and 180 days in the swimmer's plot. I...

November 29, 2023

V.TLT

RE:RE:RE:RE:RE:RE:It’s going to take a longggggg time I bet

Hi Pandora - Google says: What is an Aptamer? The term “Aptamer” was...

November 29, 2023

V.TLT

If you think Adstiladrin is exciting check out Ruvidar PDT..

The 12 month CR rate of Ruvidar PDT is 36% - and will probably end up higher,...

November 28, 2023

V.TLT

RE:Top 10 Photodynamic Therapy Clinical Trials [2023 Studies] |

I went to the site and it says there are 33 spots left in the trial. Could...

November 26, 2023

V.TLT

Dr. McFarland to speak in Hong Kong on Thursday Nov. 30

Tackling Cancer and Infection with LightResponsive Molecules City...

November 25, 2023

V.TLT

Today's TLD1433 Shout-outs

Two-photon phototriggering of ROS storm in ruthenium(II) coordinated carbon...

November 22, 2023

V.TLT

QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

We learned last month that the FDA has accepted the resubmission of a...

November 21, 2023

V.TLT

RE:RE:RE:More good news, maybe

Hi enrique - six months ago, as of 30 May 2023, 39 patients had hit 450 days ...

November 21, 2023

V.TLT

RE:More good news, maybe

Hi riverrow. Right - 29 patients should have reached 24 months post initial...

November 20, 2023

V.TLT

Longterm Treatment Followup

The FDA provides a lot more information about the Adstiladrin trial than you...

November 20, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Revive Therapeutics Ltd

Revive Therapeutics Ltd C.RVV

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ... view more »